Tirzepatide constipation: the protocol that resolves it
Constipation is the second most common tirzepatide side effect after nausea. Unlike nausea, it doesn't fade on its own. The four-part protocol that works.
The mechanism
Tirzepatide slows the entire GI tract, not just the stomach. Combined with reduced food volume (you're eating less) and reduced fluid intake (the drug mutes thirst), the conditions for chronic constipation are essentially manufactured. The slowed transit time means stool sits in the colon longer, water gets reabsorbed more thoroughly, and the result is harder, drier stool. About 7-15% of tirzepatide patients in trials reported constipation; the real-world rate is higher because patients often don't report mild constipation as a side effect.
What to expect
Unlike nausea, constipation typically peaks weeks 2-6 (not week 1) as the cumulative effect of reduced fiber + reduced fluid + slowed transit catches up. By month 3, most patients have stabilized into a slower-than-baseline GI pattern that's manageable with the right protocol. By month 6, many patients can drop intensive management and continue with passive habits.
Management
The four-part protocol: (1) Hydration with intent: body-weight-in-pounds divided by 2, in fluid ounces, daily. Add electrolytes (1/2 tsp salt per liter or any electrolyte powder). (2) Magnesium glycinate 400-600mg before bed nightly while on the drug. Single highest-leverage intervention. (3) Soluble fiber (psyllium husk 1 tbsp in water before bed). Insoluble fiber can make slow-gut constipation worse. (4) Walk 20 minutes after lunch and 20 after dinner. Peristaltic stimulus. If still stuck at 2 weeks: docusate sodium 100mg twice daily, or polyethylene glycol (Miralax) 17g daily. Both available OTC.
When to escalate
No bowel movement in 5+ days despite the protocol warrants a call to the clinic. Persistent abdominal pain or cramping that doesn't resolve with bowel movement is concerning. Blood in stool always warrants evaluation. Vomiting combined with inability to pass stool or gas suggests possible bowel obstruction (rare but serious); ER evaluation.
- SURMOUNT-1 (Jastreboff et al., NEJM 2022)